Recurrent miscarriage

New England Journal of Medicine

Volumn 363, Issue 18, 2010, Pages 1740-1747

  Branch, Ware B ^a,b   Gibson, Mark ^a   Silver, Robert M ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DALTEPARIN; ENOXAPARIN; HEPARIN; ANTICOAGULANT AGENT;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIRTH RATE; CLINICAL TRIAL; GENETIC SCREENING; GESTATIONAL AGE; HUMAN; LOW DRUG DOSE; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT ABORTION; RISK FACTOR; SPONTANEOUS ABORTION; THROMBOPHILIA; UTERUS BLEEDING; UTERUS MALFORMATION; ADULT; CHROMOSOME ABERRATION; CONGENITAL MALFORMATION; FEMALE; GENETICS; PRACTICE GUIDELINE; REVIEW; UTERUS;

ABORTION, HABITUAL; ADULT; ANTICOAGULANTS; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; THROMBOPHILIA; UTERUS;

EID: 78049433763     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcp1005330     Document Type: Article

References (55)

1. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med 1988;319:189-94.
2. Sierra S, Stephenson M. Genetics of recurrent pregnancy loss. Semin Reprod Med 2006;24:17-24.
3. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ 2000;320:1708-12. (Pubitemid 30410486)
4. Rai R, Regan L. Recurrent miscarriage. Lancet 2006;368:601-11.
5. ACOG practice bulletin: management of recurrent early pregnancy loss. No. 24. Washington, DC: American College of Obstetricians and Gynecologists, February 2001.
6. Patient's fact sheet: recurrent pregnancy loss. Birmingham, AL: American Society for Reproductive Medicine, 2008.
7. Sullivan AE, Silver RM, LaCoursiere DY, Porter TF, Branch DW. Recurrent fetal aneuploidy and recurrent miscarriage. Obstet Gynecol 2004;104:784-8.
8. Branch DW, Heuser C. Recurrent miscarriage. In: Carrell DT, Peterson CM, eds. Reproductive endocrinology and infertility: integrating modern clinical and laboratory practice. New York: Springer, 2010:281-96.
9. Mills JL, Simpson JL, Driscoll SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med 1988;319:1617-23.
10. Abalovich M, Gutierrez S, Alcaraz G, Maccallini G, Garcia A, Levalle O. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002;12:63-8.
11. The ESHRE Capri Workshop Group. Nutrition and reproduction in women. Hum Reprod Update 2006;12:193-207.
12. Mishra GD, Dobson AJ, Schofield MJ. Cigarette smoking, menstrual symptoms and miscarriage among young women. Aust N Z J Public Health 2000;24:413-20.
13. Henriksen TB, Hjollund NH, Jensen TK, et al. Alcohol consumption at the time of conception and spontaneous abortion. Am J Epidemiol 2004;160:661-7.
14. Weng X, Odouli R, Li DK. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 2008; 198(3):279.e1-279.e8.
15. Branch DW, Khamashta M. Antiphospholipid syndrome. In: Queenan JT, ed. High-risk pregnancy. Washington, DC: American College of Obstetricians and Gynecologists, 2007:60-72.
16. Robertson L, Wu O, Langhorne P, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol 2006;132:171-96.
17. Dizon-Townson D, Miller C, Sibai B, et al. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol 2005;106:517-24. (Pubitemid 41208783)
18. Silver RM, Zhao Y, Spong CY, et al. Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol 2010;115:14-20.
19. Said JM, Higgins JR, Moses EK, et al. Inherited thrombophilia polymorphisms and pregnancy outcomes in nulliparous women. Obstet Gynecol 2010;115:5-13.
20. Salim R, Regan L, Woelfer B, Backos M, Jurkovic D. A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod 2003;18:162-6.
21. Meza-Espinoza JP, Anguiano LO, Rivera H. Chromosomal abnormalities in couples with reproductive disorders. Gynecol Obstet Invest 2008;66:237-40.
22. Carp H, Toder V, Aviram A, Daniely M, Mashiach S, Barkai G. Karyotype of the abortus in recurrent miscarriage. Fertil Steril 2001;75:678-82.
23. Duggan MA, Brashert P, Ostor A, et al. The accuracy and interobserver reproducibility of endometrial dating. Pathology 2001;33:292-7.
24. Jordan J, Craig K, Clifton DK, Soules MR. Luteal phase defect: the sensitivity and specificity of diagnostic methods in common use. Fertil Steril 1994;62:54-62.
25. The investigation and treatment of women with recurrent miscarriage. RCOG guideline no. 17. London: Royal College of Obstetricians and Gynaecologists, 2003.
26. Ober C, Karrison T, Odem RR, et al. Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 1999;354:365-9.
27. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod 1999;14:2868-71.
28. Kutteh WH. Antiphospholipid antibody- associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996;174:1584-9.
29. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314:253-7.
30. Farquharson RG, Quenby S, Greaves M. Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 2002;100:408-13. [Erratum, Obstet Gynecol 2002;100: 1361.]
31. Laskin CA, Spitzer K, Clark CA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial. J Rheumatol 2009;36:279-87.
32. Gris JC, Mercier E, Quéré I, et al. Low-molecular- weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 2004;103:3695-9.
33. Warren JE, Simonsen SE, Branch DW, Porter TF, Silver RM. Thromboprophylaxis and pregnancy outcomes in asymptomatic women with inherited thrombophilias. Am J Obstet Gynecol 2009;200(3): 281.e1-281.e5.
34. Bates SM, Greer IA, Pabinger I, et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:Suppl:844S-866S.
35. Kaandorp SP, Goddijn M, van der Post JAM, et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage. N Engl J Med 2010;362:1586-96.
36. Clark P, Walker ID, Langhorne P, et al. SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage. Blood 2010;115:4162-7.
37. Heinonen PK. Reproductive performance of women with uterine anomalies after abdominal or hysteroscopic metroplasty or no surgical treatment. J Am Assoc Gynecol Laparosc 1997;4:311-7.
38. Valli E, Vaquero E, Lazzarin N, Caserta D, Marconi D, Zupi E. Hysteroscopic metroplasty improves gestational outcome in women with recurrent spontaneous abortion. J Am Assoc Gynecol Laparosc 2004;11:240-4.
39. Ashton D, Amin HK, Richart RM, Neuwirth RS. The incidence of asymptomatic uterine anomalies in women undergoing transcervical tubal sterilization. Obstet Gynecol 1988;72:28-30.
40. Heinonen PK. Complete septate uterus with longitudinal vaginal septum. Fertil Steril 2006;85:700-5.
41. Engels H, Eggermann T, Caliebe A, et al. Genetic counseling in Robertsonian translocations der(13;14): frequencies of reproductive outcome and infertility in 101 pedigrees. Am J Med Genet 2008;146A: 2611-6.
42. Keymolen K, Staessen C, Verpoest W, et al. A proposal for reproductive counseling in carriers of Robertsonian translocations: 10 years of experience with preimplantation genetic diagnosis. Hum Reprod 2009;24:2365-71.
43. Staessen C, Platteau P, Van Assche E, et al. Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 2004;19:2849-58.
44. The Practice Committee of the Society for Assisted Reproductive Technology, Practice Committee for the American Society for Reproductive Medicine. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril 2008;90: 5 Suppl:S136-S143.
45. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006;2: CD000112.
46. Report of the Obstetric Task Force: 13th International Congress on Antiphospholipid Antibodies, 13 April 2010. Lupus (in press).
47. Warren JE, Silver RM. Genetics of pregnancy loss. Clin Obstet Gynecol 2008; 51:84-95.
48. Warren JE, Turok DK, Maxwell TM, Brothman AR, Silver RM. Array comparative genomic hybridization for genetic evaluation of fetal loss between 10 and 20 weeks gestation. Obstet Gynecol 2009; 114:1093-102.
49. Klatsky PC, Tran ND, Caughey AB, Fujimoto VY. Fibroids and reproductive outcomes: a systematic literature review from conception to delivery. Am J Obstet Gynecol 2008;198:357-66.
50. Pritts EA, Parker WH, Olive DL. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril 2009;91:1215-23.
51. Clifford K, Rai R, Watson H, Franks S, Regan L. Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. BMJ 1996;312:1508-11.
52. Rai R, Backos M, Rushworth F, Regan L. Polycystic ovaries and recurrent miscarriage - a reappraisal. Hum Reprod 2000;15:612-5.
53. Legro RS, Barnhart HX, Schlaff WD, et al. Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med 2007;356:551-66.
54. Craig LB, Ke RW, Kutteh WH. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril 2002;78:487-90.
55. Palomba S, Falbo A, Orio F, Zullo F. Effect of preconceptional metformin on abortion risk in polycystic ovary syndrome: a systematic review and metaanalysis of randomized controlled trials. Fertil Steril 2009;92:1646-58.